Stay updated on Fazirsiran Safety & Efficacy Clinical Trial

Sign up to get notified when there's something new on the Fazirsiran Safety & Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fazirsiran Safety & Efficacy Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    - Add: a government-funding notice with operating status and official sources; - Add: version upgrade to v3.2.0; - Remove: version v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T05:48:25.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Appended version label (v3.1.0) and removal of multiple drug-safety related sections, indicating content consolidation and reorganization rather than new substantive content.
    Difference
    0.3%
    Check dated 2025-09-29T03:11:41.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2, indicating a new release. The 'Back to Top' element was removed as a minor UI cleanup.
    Difference
    0.1%
    Check dated 2025-09-14T19:54:48.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.1%
    Check dated 2025-09-07T16:56:33.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The web page has been updated to include a new facility name and location details, as well as significant information regarding drug safety and a clinical trial related to alpha 1-antitrypsin deficiency. Additionally, there have been revisions to the versioning of the content.
    Difference
    3%
    Check dated 2025-08-31T12:10:29.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The webpage has been updated to include new information about the clinical study AROAAT2001 (SEQUOIA), including details about the investigational product Fazirsiran and its administration to participants with alpha-1 antitrypsin deficiency. Additionally, the page now features a disclaimer regarding the U.S. government's review of studies listed on the site.
    Difference
    100%
    Check dated 2025-08-17T04:29:26.000Z thumbnail image

Stay in the know with updates to Fazirsiran Safety & Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fazirsiran Safety & Efficacy Clinical Trial page.